vai alle Pubblicazioni
Publications prior to 2004
Carli S, Chaabane L, De Rocco G, Albizzati E, Sormonta I, Calligaro S, Bonizzi P, Frasca A, Landsberger N. A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain. Neurobiol Dis. 2023 Mar 15:106083. doi: 10.1016/j.nbd.2023.106083. PMID: 36931532.
Carli S. Identification and validation of novel measurable outcomes for Rett syndrome through MRI and preclinical studies, PhD Thesis, 2022 May 13. (XXXIV Ciclo, Anno Accademico 2020/2021). Link: hdl.handle.net/20.500.11768/133062
Carli S, Chaabane L, Butti C, De Palma C, Aimar P, Salio C, Vignoli A, Giustetto M, Landsberger N, Frasca A. In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions. J Neurochem. 2021 May;157(4):1253-1269. doi: 10.1111/jnc.15300. Epub 2021 Feb 2. PMID: 33448385.
Gandaglia A, Brivio E, Carli S, Palmieri M, Bedogni F, Stefanelli G, Bergo A, Leva B, Cattaneo C, Pizzamiglio L, Cicerone M, Bianchi V, Kilstrup-Nielsen C, D'Annessa I, Di Marino D, D'Adamo P, Antonucci F, Frasca A, Landsberger N. A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome. Mol Neurobiol. 2019 Jul;56(7):4838-4854. doi: 10.1007/s12035-018-1412-2. Epub 2018 Nov 6. PMID: 30402709.
